Your Thesis in 180 Seconds

Three-Minute Thesis competitions are designed to help young researchers refine their communication skills, but not everyone is convinced they are effective.

Written byDan Cossins
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Jasdeep Saggar in full flow at 3MT OntarioCHI YAN LAM, QUEEN'S UNIVERSITYWith a giant digital clock counting down the seconds, 30 graduate students last week (18 April) nervously took the stage at Queen’s University in Kingston, Ontario, to explain their research to a panel of non-specialist judges in just 3 minutes. It was the final of the Ontario Three-Minute Thesis (3MT) contest, the culmination of a province-wide competition in which hundreds of early career researchers presented complex research to a lay audience in an accessible and engaging way—with a single slide and only 180 seconds.

“It was exhilarating,” said Jasdeep Saggar, a PhD candidate at the University of Toronto who took first prize—and CA$1,000—for her talk on chemotherapy and hypoxia-activated pro-drugs in the breast cancer tumor microenvironment. “I was nervous, because it was a packed house, but this was my moment to talk about almost 5 years of my life, something that I’m very passionate about.”

Originally developed by the University of Queensland in Australia, 3MT aims to promote communication across research disciplines and help young academics develop skills to effectively share their work with a broad audience. For the scientists competing, the hope is that such skills will help them advance their careers, as well as prepare them to better communicate their work to the public. But some scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies